frontdoor FTDR 深 沪
等待开盘 07-21 09:30:00 美东时间
57.78
-0.410
-0.70%
华盛通- 最 高58.73
- 今 开58.60
- 成交量 57.85万股
- 最 低 57.73
- 昨 收 58.19
- 总市值 42.52亿
- 52周最高 63.4875
- 市盈率 静 19.18
- 换手率 0.79%
- 52周最低 35.61
- 委 比 65.38%
- 总股本 7358.58万
- 历史最高 63.4875
- 量 比 1.37
- 振 幅 1.72%
- 历史最低 19.06
- 每 手 1
- 风险率 7.47%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多P/E Ratio Insights for Frontdoor
In the current session, the stock is trading at $59.93, after a 2.62% increase....
07-05 03:00
Frontdoor Appoints New CTO to Boost Innovation
An announcement from frontdoor ( ($FTDR) ) is now available. On June 24, 2025, ...
06-25 20:58
美股大行评级 | 潜在涨幅417.8%！RBC Capital上调Perspective Therapeutics目标价至16美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1136940401951563776.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital：维持Perspective Therapeutics(CATX)"跑赢大市"评级，目标价从15美元升至16美元</p> <p>• Canaccord Genuity：维持Taysha Gene Th
06-04 08:35
JP Morgan Maintains Neutral on Frontdoor, Raises Price Target to $55
JP Morgan analyst Cory Carpenter maintains Frontdoor (NASDAQ:FTDR) with a Neutral and raises the price target from $50 to $55.
06-03 20:06
frontdoor (FTDR) Receives a Hold from KeyBanc
KeyBanc analyst Justin Patterson maintained a Hold rating on frontdoor (FTDR – ...
05-05 15:07
Earnings Scheduled For May 1, 2025
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repor...
05-01 16:32
JP Morgan Downgrades Frontdoor to Neutral, Lowers Price Target to $40
JP Morgan analyst Cory Carpenter downgrades Frontdoor (NASDAQ:FTDR) from Overweight to Neutral and lowers the price target from $58 to $40.
04-22 19:11
美股大行评级 | Piper Sandler：上调ACNB Corp评级至"超配"，目标价从37美元升至50美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1103601922058588161.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行：维持Rocket Pharmaceuticals(RCKT)"跑赢大市"评级，目标价从51美元升至52美元</p> <p>• HC Wainwright & Co.：维持Revolution Medici
03-04 08:54
KeyBanc Sticks to Their Hold Rating for frontdoor (FTDR)
In a report released today, Justin Patterson from KeyBanc maintained a Hold rat...
03-03 15:26
